Research Topics
| James A ReiffelSummaryAffiliation: Columbia University Country: USA Publications
|
Detail Information
Publications
Atrial fibrillation: what have recent trials taught us regarding pharmacologic management of rate and rhythm control?James A Reiffel
Department of Medicine, Division of Cardiology, Electrophysiology Section, Columbia University Medical Center, New York, New York 10032, USA
Pacing Clin Electrophysiol 34:247-59. 2011..This review examines the clinical outcomes of several important AF trials, discusses the limitations in applying the major morbidity/mortality findings to everyday clinical practice, and summarizes the lessons learned...- Atypical proarrhythmia with dofetilide: monomorphic VT and exercise-induced torsade de pointesJames A Reiffel
Electrophysiology Service, Department of Medicine, Division of Cardiology, Columbia University, New York, NY, USA
Pacing Clin Electrophysiol 28:877-9. 2005.... - Practical algorithms for pharmacologic management of the post myocardial infarction patientJames A Reiffel
Cardiology Division, Department of Medicine, Columbia University, New York, New York, USA
Clin Cardiol 28:I28-37. 2005..Current guidelines also recommend that patients post MI with elevated cholesterol levels should be prescribed lipid therapy with a statin at hospital discharge... - Antiarrhythmic effects of omega-3 fatty acidsJames A Reiffel
Division of Cardiology, Department of Medicine, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York 10032, USA
Am J Cardiol 98:50i-60i. 2006.... - Adjunctive therapy for recurrent ventricular tachycardia in patients with implantable cardioverter defibrillatorsJames A Reiffel
Columbia University, 161 Fort Washington Avenue, New York, NY 10032, USA
Curr Cardiol Rep 9:381-6. 2007..This review describes the considerations important to the use of these therapies in ICD patients and the results and applicability of these investigative studies... - Demystifying the rate versus rhythm conundrum: new perspectives on recent trials and future treatment options. IntroductionJames A Reiffel
Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
Am J Cardiol 102:1H-2H. 2008 - A contemporary look at classic trials in atrial fibrillation: what do they really show and how might they apply to future therapies?James A Reiffel
Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
Am J Cardiol 102:3H-11H. 2008..Importantly, as the armamentarium of AF management strategies is broadened, the risk/efficacy balance must continue to be evaluated on a patient-specific basis... - Cardioversion for atrial fibrillation: treatment options and advancesJames A Reiffel
Department of Medicine, Division of Cardiology, Section of Electrophysiology, Columbia University, New York, New York 10032, USA
Pacing Clin Electrophysiol 32:1073-84. 2009..In conclusion, further trials should clarify the long-term safety profiles of new atrioselective agents and other investigational drugs and define their role in the treatment of AF... - Practice patterns among United States cardiologists for managing adults with atrial fibrillation (from the AFFECTS Registry)James A Reiffel
Columbia University, New York, NY, USA
Am J Cardiol 105:1122-9. 2010..In conclusion, data from this study provide insight into community treatment patterns in patients with AF, most without clinically significant structural heart disease or with only uncomplicated hypertension... - Drug and drug-device therapy in heart failure patients in the post-COMET and SCD-HeFT eraJames A Reiffel
Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA
J Cardiovasc Pharmacol Ther 10:S45-58. 2005.... - Comparison of autotriggered memory loop recorders versus standard loop recorders versus 24-hour Holter monitors for arrhythmia detectionJames A Reiffel
Division of Cardiology, Department of Medicine, Columbia University, New York, New York 10032, USA
Am J Cardiol 95:1055-9. 2005..Further, the higher yield of AT-MLR versus MLR demonstrates the significantly enhanced benefit of autotriggered programmable recording... - Formulation substitution: a frequently overlooked variable in cardiovascular drug managementJames A Reiffel
Division of Cardiology, Department of Medicine, Columbia University College of Physicians and Surgeons, The New York Presbytarian Hospital, New York, NY, USA
Prog Cardiovasc Dis 47:3-10. 2004 - Have sanctioned algorithms replaced empiric judgment in the selection process of antiarrhythmic drugs for the therapy for atrial fibrillation?James A Reiffel
Columbia Presbyterian Hospital, Division of Cardiology, 161 Fort Washington Avenue, New York, NY 10032, USA
Curr Cardiol Rep 6:365-70. 2004.... - Will direct thrombin inhibitors replace warfarin for preventing embolic events in atrial fibrillation?James A Reiffel
Department of Clinical Medicine, Columbia University, New York, New York, USA
Curr Opin Cardiol 19:58-63. 2004.... - Is arterial stiffness a contributing factor to atrial fibrillation in patients with hypertension? A preliminary investigationJames A Reiffel
Division of Cardiology, Department of Medicine, Columbia University and The New York Presbyterian Hospital, 161 Fort Washington Avenue, New York, NY 10032, USA
Am J Hypertens 17:213-6. 2004..Alternatively, it may be a more indirect and complex relationship involving chronic morphologic, electrophysiologic, and secretory consequences in the atrium consequent to a chronically reduced left ventricular (LV) compliance... - Autonomic modulation of the u wave during sympathomimetic stimulation and vagal inhibition in normal individualsAnthony R Magnano
Department of Medicine, Division of Cardiology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
Pacing Clin Electrophysiol 27:1484-92. 2004..Thus, the U wave represents a component of cardiac repolarization that is electrocardiographically and physiologically distinct from the T wave with a unique response to sympathomimetic stimulation... - Antiarrhythmic drug therapy for atrial fibrillation: are the guidelines guiding clinical practice?James A Reiffel
Columbia University Medical Center, 161 Fort Washington Ave, New York, NY 10032, USA
Clin Cardiol 29:97-102. 2006..However, market research and clinical study data indicate a growing use of class III agents (mainly amiodarone) despite long-term safety and tolerability concerns, suggesting that clinical practice does not adhere to current guidelines... - Drug therapy for atrial fibrillation: what will its role be in the era of increasing use of catheter ablation?John P Morrow
Department of Medicine, Division of Cardiology, New York Presbyterian Hospital, Columbia University, New York, NY 10032, USA
Pacing Clin Electrophysiol 32:108-18. 2009..If ablation techniques improve, one might ask whether there will still be a role for AADs, and, if so, what will it be and what agents will be used. This manuscript will attempt to answer these questions... - Device therapies in the post-myocardial infarction patient with left ventricular dysfunctionAlan H Kadish
Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
Am J Cardiol 102:29G-37G. 2008..Further risk stratification studies of post-MI LVD patients will allow ICD therapy to be applied in a more cost-effective manner... - New antiarrhythmic drugs for establishing sinus rhythm in atrial fibrillation: what are our therapies likely to be by 2010 and beyond?John P Morrow
The Division of Cardiology, Department of Medicine, Columbia University, New York, NY, USA
Am Heart J 154:824-9. 2007.... - The potential for changing prescribing patterns from warfarin to oral direct thrombin inhibitors: clinical scenariosJames A Reiffel
Department of Medicine, Division of Cardiology, Columbia University College of Physicians and Surgeons, New York, New York, USA
Rev Cardiovasc Med 5:S12-21. 2004..Therefore, clinicians should diligently follow the medical literature regarding the latest information on this agent... - Microcomplex--a new incomplete heart block patternJames A Reiffel
Cardiology Division, Department of Medicine, Columbia University, NYC, NY, USA
J Electrocardiol 35:273-8. 2002.... - Autonomic nervous system influences on QT interval in normal subjectsAnthony R Magnano
Department of Medicine, Division of Cardiology, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032, USA
J Am Coll Cardiol 39:1820-6. 2002..Our findings demonstrate that autonomic conditions directly affect the ventricular myocardium of healthy subjects, causing differences in QT that are independent of HR... - Cardiology patient page. The implantable cardioverter-defibrillator: patient perspectiveJames A Reiffel
Division of Cardiology, Division of Medicine, Columbia University, and the New York Presbyterian Hospital, New York, NY, USA
Circulation 105:1022-4. 2002